These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9724860

  • 21. Single dose 'ROM' therapy--is it really effective?
    Mandal AK.
    Natl Med J India; 1998; 11(5):247. PubMed ID: 10997176
    [No Abstract] [Full Text] [Related]

  • 22. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG, Fajardo TT, Abalos RM, Cellona RV, Balagon MV, Dela Cruz EC, Tan EV, Walsh GP, Walsh DS.
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group.
    Indian J Lepr; 1997 Feb; 69(2):121-9. PubMed ID: 9290963
    [Abstract] [Full Text] [Related]

  • 26. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P, Bundit C, Kuhacharoen N, Peerapakorn S, Kampirapap K, Poomlek A, Bampenyu S, Tiasiri S, Rungruang S, Surasondhi S, Supanwanit S, Wiriyawipart S.
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chemotherapy of leprosy.
    Biswas SK, WHO.
    J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
    [Abstract] [Full Text] [Related]

  • 29. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL, Stefani MM, Pereira GA, Costa MB, Rebello PF, Gomes MK, Narahashi K, Gillis TP, Krahenbuhl JL, Martelli CM.
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine].
    Diniz LM, Catabriga MD, Souza Filho JB.
    Rev Soc Bras Med Trop; 2010 Nov; 43(6):695-9. PubMed ID: 21181026
    [Abstract] [Full Text] [Related]

  • 31. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A, Girdhar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2015 Nov; 81(4):356-62. PubMed ID: 26144850
    [Abstract] [Full Text] [Related]

  • 32. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN.
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract] [Full Text] [Related]

  • 33. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [Abstract] [Full Text] [Related]

  • 34. Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
    Tin K.
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S26-9. PubMed ID: 10700934
    [No Abstract] [Full Text] [Related]

  • 35. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S, Reddy R.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract] [Full Text] [Related]

  • 36. Elimination of leprosy in the federated states of micronesia by intensive case finding, treatment with WHO/MDT and administration of chemoprophylaxis.
    Diletto C.
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S10-3. PubMed ID: 10700929
    [No Abstract] [Full Text] [Related]

  • 37. Multibacillary leprosy: follow up observations on 19 patients treated with 12 monthly doses of rifampicin, ofloxacin and minocycline therapy in Agra.
    Kumar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2014 Dec; 80(2):156-9. PubMed ID: 24685858
    [No Abstract] [Full Text] [Related]

  • 38. Population screening and mass chemoprophylaxis in Kiribati.
    Daulako EC.
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S23-5. PubMed ID: 10700933
    [No Abstract] [Full Text] [Related]

  • 39. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
    [No Abstract] [Full Text] [Related]

  • 40. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M, Gupte MD.
    Indian J Lepr; 2005 Mar; 77(1):19-25. PubMed ID: 16173416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.